← All trials
NCT00952861
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2009
- Primary completion
- Oct 31, 2010
- Completion date
- Dec 31, 2010
- First posted
- Aug 6, 2009
- Last posted
- Aug 11, 2010
- Enrollment
- 140
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Southern DenmarkLead sponsor
- Danish National Research FoundationCollaborator
- Danmarks LungeforeningCollaborator
- University of CopenhagenCollaborator
- Region SyddanmarkCollaborator
- Naestved HospitalCollaborator
- University of Southern DenmarkStudy chair
- Region SyddanmarkCollaborator
- Svendborg HospitalCollaborator
- University of Southern DenmarkOfficial
- Fredericia HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.